Skip to Main Content

NTLA logo

Intellia Therapeutics, Inc

N/A USD
N/A
N/A
...
Chart
Financials
Description
NTLA Company Description

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

NTLA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NTLA Smart Score

Score Breakdown
NTLA Company Description

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis. Show Less

Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of NTLA by members of U.S. Congress

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login

Recently reported changes by institutional investors

Quiver Logo

Sign Up for Access

Sign Up or Login

Quarterly net insider trading by NTLA's directors and management

Quiver Logo

Sign Up for Access

Sign Up or Login

Government lobbying spending instances

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
U.S. Patents

New patents grants

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Government Contracts

Federal grants, loans, and purchases

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
WallStreetBets

Number of mentions of NTLA in WallStreetBets Daily Discussion

Quiver Logo

Sign Up for Access

Sign Up or Login
NTLA News

Recent insights relating to NTLA

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
CNBC Recommendations

Recent picks made for NTLA stock on CNBC

  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Top ETF Holders

ETFs with the largest estimated holdings in NTLA

  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Corporate Flights

Flights by private jets registered to NTLA

  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Back To Top